Regkirona, COVID-19 antibody treatment developed by Celltrion, will be sold overseas.

Celltrion Healthcare announced on the 10th that it plans to sign a contract for 100,000 vials of Regkirona with a subsidiary of Pakistan's largest order factories (POF) under the Ministry of National Defense and ship the contract.

"Regkirona has been approved for emergency use by certain groups before obtaining official permission from Pakistani health authorities," the company said.

Regkirona, which will be sold as the first batch, will be administered to confirmed COVID-19 patients among Pakistani soldiers and ordinary people. 100,000 vials with contracts can be administered to about 30,